Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study

Coronary access (CA) after transcatheter aortic valve replacement (TAVR) with supra-annular transcatheter heart valves (THV) can be challenging. Specific Evolut R/Pro and Acurate Neo THVs orientations are associated with reduced neo-commissure overlap with coronary ostia, while SAPIEN 3 THV cannot b...

Full description

Saved in:
Bibliographic Details
Published inCirculation. Cardiovascular interventions Vol. 15; no. 2; p. e011045
Main Authors Tarantini, Giuseppe, Nai Fovino, Luca, Scotti, Andrea, Massussi, Mauro, Cardaioli, Francesco, Rodinò, Giulio, Benedetti, Alice, Boiago, Mauro, Matsuda, Yuji, Continisio, Saverio, Montonati, Carolina, Cacciavillani, Luisa, Pavei, Andrea, Masiero, Giulia, Napodano, Massimo, Fraccaro, Chiara, Fabris, Tommaso, Iliceto, Sabino
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 01.02.2022
Subjects
Online AccessGet full text
ISSN1941-7632
1941-7640
1941-7632
DOI10.1161/CIRCINTERVENTIONS.121.011045

Cover

Abstract Coronary access (CA) after transcatheter aortic valve replacement (TAVR) with supra-annular transcatheter heart valves (THV) can be challenging. Specific Evolut R/Pro and Acurate Neo THVs orientations are associated with reduced neo-commissure overlap with coronary ostia, while SAPIEN 3 THV cannot be oriented. With the ALIGN-ACCESS study (TAVR With Commissural Alignment Followed by Coronary Access), we investigated the impact of commissural alignment on the feasibility of CA after TAVR. We performed coronary angiography after TAVR with intra-annular SAPIEN 3, supra-annular Evolut R/Pro, and Acurate Neo THVs in 206 patients. Evolut THVs were implanted aiming for commissure alignment. Alignment of Acurate Neo was retrospectively assessed in 36, intentionally attempted in 26 cases. The primary end point was the rate of unfeasible and nonselective CA after TAVR. Thirty-eight percent of patients received SAPIEN 3, 31.1% Evolut Pro/R, 30.1% Acurate Neo THV. Final valve orientation was favorable to commissural alignment in 85.9% of Evolut and 69.4% of Acurate Neo cases (with intentional alignment successful in 88.5%). Selective CA was higher for SAPIEN 3 than for aligned and misaligned supra-annular THVs (95% versus 71% versus 46%, <0.001). Cannulation of at least one coronary was unfeasible with 11% misaligned supra-annular, 3% aligned supra-annular, and 0% SAPIEN 3 THVs. Independent predictors of unfeasible/nonselective CA were implantation of a misaligned supra-annular THV (odds ratio, 4.59 [95% CI, 1.81-11.61]; <0.01), sinus of Valsalva height (odds ratio, 0.83 [95% CI, 0.7-0.98]; =0.03), and THV-sinus of Valsalva relation (odds ratio, 1.06 [95% CI, 1.02-1.1]; <0.01). Commissural alignment improves the rate of selective CA after TAVR with supra-annular THVs. Nevertheless, aligned supra-annular THVs carry higher risk of unfeasible/nonselective CA than SAPIEN 3. Patients with a misaligned supra-annular THV, low sinus of Valsalva, and higher THV-sinus of Valsalva relation are at highest risk of impaired CA after TAVR.
AbstractList Coronary access (CA) after transcatheter aortic valve replacement (TAVR) with supra-annular transcatheter heart valves (THV) can be challenging. Specific Evolut R/Pro and Acurate Neo THVs orientations are associated with reduced neo-commissure overlap with coronary ostia, while SAPIEN 3 THV cannot be oriented. With the ALIGN-ACCESS study (TAVR With Commissural Alignment Followed by Coronary Access), we investigated the impact of commissural alignment on the feasibility of CA after TAVR. We performed coronary angiography after TAVR with intra-annular SAPIEN 3, supra-annular Evolut R/Pro, and Acurate Neo THVs in 206 patients. Evolut THVs were implanted aiming for commissure alignment. Alignment of Acurate Neo was retrospectively assessed in 36, intentionally attempted in 26 cases. The primary end point was the rate of unfeasible and nonselective CA after TAVR. Thirty-eight percent of patients received SAPIEN 3, 31.1% Evolut Pro/R, 30.1% Acurate Neo THV. Final valve orientation was favorable to commissural alignment in 85.9% of Evolut and 69.4% of Acurate Neo cases (with intentional alignment successful in 88.5%). Selective CA was higher for SAPIEN 3 than for aligned and misaligned supra-annular THVs (95% versus 71% versus 46%, <0.001). Cannulation of at least one coronary was unfeasible with 11% misaligned supra-annular, 3% aligned supra-annular, and 0% SAPIEN 3 THVs. Independent predictors of unfeasible/nonselective CA were implantation of a misaligned supra-annular THV (odds ratio, 4.59 [95% CI, 1.81-11.61]; <0.01), sinus of Valsalva height (odds ratio, 0.83 [95% CI, 0.7-0.98]; =0.03), and THV-sinus of Valsalva relation (odds ratio, 1.06 [95% CI, 1.02-1.1]; <0.01). Commissural alignment improves the rate of selective CA after TAVR with supra-annular THVs. Nevertheless, aligned supra-annular THVs carry higher risk of unfeasible/nonselective CA than SAPIEN 3. Patients with a misaligned supra-annular THV, low sinus of Valsalva, and higher THV-sinus of Valsalva relation are at highest risk of impaired CA after TAVR.
Coronary access (CA) after transcatheter aortic valve replacement (TAVR) with supra-annular transcatheter heart valves (THV) can be challenging. Specific Evolut R/Pro and Acurate Neo THVs orientations are associated with reduced neo-commissure overlap with coronary ostia, while SAPIEN 3 THV cannot be oriented. With the ALIGN-ACCESS study (TAVR With Commissural Alignment Followed by Coronary Access), we investigated the impact of commissural alignment on the feasibility of CA after TAVR.BACKGROUNDCoronary access (CA) after transcatheter aortic valve replacement (TAVR) with supra-annular transcatheter heart valves (THV) can be challenging. Specific Evolut R/Pro and Acurate Neo THVs orientations are associated with reduced neo-commissure overlap with coronary ostia, while SAPIEN 3 THV cannot be oriented. With the ALIGN-ACCESS study (TAVR With Commissural Alignment Followed by Coronary Access), we investigated the impact of commissural alignment on the feasibility of CA after TAVR.We performed coronary angiography after TAVR with intra-annular SAPIEN 3, supra-annular Evolut R/Pro, and Acurate Neo THVs in 206 patients. Evolut THVs were implanted aiming for commissure alignment. Alignment of Acurate Neo was retrospectively assessed in 36, intentionally attempted in 26 cases. The primary end point was the rate of unfeasible and nonselective CA after TAVR.METHODSWe performed coronary angiography after TAVR with intra-annular SAPIEN 3, supra-annular Evolut R/Pro, and Acurate Neo THVs in 206 patients. Evolut THVs were implanted aiming for commissure alignment. Alignment of Acurate Neo was retrospectively assessed in 36, intentionally attempted in 26 cases. The primary end point was the rate of unfeasible and nonselective CA after TAVR.Thirty-eight percent of patients received SAPIEN 3, 31.1% Evolut Pro/R, 30.1% Acurate Neo THV. Final valve orientation was favorable to commissural alignment in 85.9% of Evolut and 69.4% of Acurate Neo cases (with intentional alignment successful in 88.5%). Selective CA was higher for SAPIEN 3 than for aligned and misaligned supra-annular THVs (95% versus 71% versus 46%, P<0.001). Cannulation of at least one coronary was unfeasible with 11% misaligned supra-annular, 3% aligned supra-annular, and 0% SAPIEN 3 THVs. Independent predictors of unfeasible/nonselective CA were implantation of a misaligned supra-annular THV (odds ratio, 4.59 [95% CI, 1.81-11.61]; P<0.01), sinus of Valsalva height (odds ratio, 0.83 [95% CI, 0.7-0.98]; P=0.03), and THV-sinus of Valsalva relation (odds ratio, 1.06 [95% CI, 1.02-1.1]; P<0.01).RESULTSThirty-eight percent of patients received SAPIEN 3, 31.1% Evolut Pro/R, 30.1% Acurate Neo THV. Final valve orientation was favorable to commissural alignment in 85.9% of Evolut and 69.4% of Acurate Neo cases (with intentional alignment successful in 88.5%). Selective CA was higher for SAPIEN 3 than for aligned and misaligned supra-annular THVs (95% versus 71% versus 46%, P<0.001). Cannulation of at least one coronary was unfeasible with 11% misaligned supra-annular, 3% aligned supra-annular, and 0% SAPIEN 3 THVs. Independent predictors of unfeasible/nonselective CA were implantation of a misaligned supra-annular THV (odds ratio, 4.59 [95% CI, 1.81-11.61]; P<0.01), sinus of Valsalva height (odds ratio, 0.83 [95% CI, 0.7-0.98]; P=0.03), and THV-sinus of Valsalva relation (odds ratio, 1.06 [95% CI, 1.02-1.1]; P<0.01).Commissural alignment improves the rate of selective CA after TAVR with supra-annular THVs. Nevertheless, aligned supra-annular THVs carry higher risk of unfeasible/nonselective CA than SAPIEN 3. Patients with a misaligned supra-annular THV, low sinus of Valsalva, and higher THV-sinus of Valsalva relation are at highest risk of impaired CA after TAVR.CONCLUSIONSCommissural alignment improves the rate of selective CA after TAVR with supra-annular THVs. Nevertheless, aligned supra-annular THVs carry higher risk of unfeasible/nonselective CA than SAPIEN 3. Patients with a misaligned supra-annular THV, low sinus of Valsalva, and higher THV-sinus of Valsalva relation are at highest risk of impaired CA after TAVR.
Author Masiero, Giulia
Scotti, Andrea
Massussi, Mauro
Nai Fovino, Luca
Cardaioli, Francesco
Montonati, Carolina
Cacciavillani, Luisa
Fraccaro, Chiara
Continisio, Saverio
Pavei, Andrea
Iliceto, Sabino
Tarantini, Giuseppe
Boiago, Mauro
Napodano, Massimo
Fabris, Tommaso
Rodinò, Giulio
Benedetti, Alice
Matsuda, Yuji
AuthorAffiliation Department of Cardiovascular Medicine, Graduate School of General Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan (Y.M.)
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
AuthorAffiliation_xml – name: Department of Cardiovascular Medicine, Graduate School of General Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan (Y.M.)
– name: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
Author_xml – sequence: 1
  givenname: Giuseppe
  surname: Tarantini
  fullname: Tarantini, Giuseppe
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 2
  givenname: Luca
  surname: Nai Fovino
  fullname: Nai Fovino, Luca
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 3
  givenname: Andrea
  surname: Scotti
  fullname: Scotti, Andrea
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 4
  givenname: Mauro
  surname: Massussi
  fullname: Massussi, Mauro
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 5
  givenname: Francesco
  surname: Cardaioli
  fullname: Cardaioli, Francesco
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 6
  givenname: Giulio
  surname: Rodinò
  fullname: Rodinò, Giulio
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 7
  givenname: Alice
  surname: Benedetti
  fullname: Benedetti, Alice
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 8
  givenname: Mauro
  surname: Boiago
  fullname: Boiago, Mauro
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 9
  givenname: Yuji
  surname: Matsuda
  fullname: Matsuda, Yuji
  organization: Department of Cardiovascular Medicine, Graduate School of General Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan (Y.M.)
– sequence: 10
  givenname: Saverio
  surname: Continisio
  fullname: Continisio, Saverio
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 11
  givenname: Carolina
  surname: Montonati
  fullname: Montonati, Carolina
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 12
  givenname: Luisa
  surname: Cacciavillani
  fullname: Cacciavillani, Luisa
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 13
  givenname: Andrea
  surname: Pavei
  fullname: Pavei, Andrea
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 14
  givenname: Giulia
  surname: Masiero
  fullname: Masiero, Giulia
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 15
  givenname: Massimo
  surname: Napodano
  fullname: Napodano, Massimo
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 16
  givenname: Chiara
  surname: Fraccaro
  fullname: Fraccaro, Chiara
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 17
  givenname: Tommaso
  surname: Fabris
  fullname: Fabris, Tommaso
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
– sequence: 18
  givenname: Sabino
  surname: Iliceto
  fullname: Iliceto, Sabino
  organization: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy (G.T., L.N.F., A.S., M.M., F.C., G.R., A.B., M.B., S.C., C.M., L.C., A.P., G.M., M.N., C.F., T.F., S.I.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35167332$$D View this record in MEDLINE/PubMed
BookMark eNqNUU2P0zAQtdAidrfwF5APHLik-CtOg-AQorJEqrpSG5Zj5LgOCbh2sZ2t-u9xlQUBe0GyPWPNm_F7z9fgwlijAHiF0Rxjjt-U1aas1vVyc7dc19XtejvHBM8RxoilT8AVzhlOMk7JxR_5Jbj2_htCMeXkGbikKeYZpeQK2NI6a4Q7wUJK5T0suqAcrJ0wXorQq_OtsC4MEt4Jfa_gRh20kGqvTIBfhtDD0u73g_ejExoWevhqzqW3sO4VLFbVzTopynK53cJtGHen5-BpJ7RXLx7iDHz-uKzLT8nq9qYqi1UiGSEkwQzRXbZoU8wy1uGWUt4RlDGKiORsIUTOEem6WErTNuWiRR2XhKO0FW1LuaIz8H6aO5qDOB2F1s3BDfsotMGoORvZyMHJwUR995HvYI1vopHNZGTsfz31H5z9MSofmqhRKq2FUXb0TfQxp4scxXMGXj5Ax3avdr_f-WVyBLybANJZ753qHlF59Kd_U_nwT7scgjgzDk4M-n-HsGnI0eoo2X_X41G5pldChz6CKM1YniYEkbgQQkncmNCfb9m6Ew
CitedBy_id crossref_primary_10_1016_j_amjcard_2023_02_032
crossref_primary_10_3389_fcvm_2022_927642
crossref_primary_10_1016_j_jacc_2024_11_051
crossref_primary_10_1186_s12872_023_03397_3
crossref_primary_10_1007_s12928_023_00918_x
crossref_primary_10_1002_ccd_30653
crossref_primary_10_1093_ehjcr_ytac399
crossref_primary_10_1016_j_jcin_2024_07_042
crossref_primary_10_1016_j_jcin_2023_05_004
crossref_primary_10_1016_j_cjca_2024_07_030
crossref_primary_10_1016_j_jcin_2022_05_005
crossref_primary_10_3389_fcvm_2022_1004103
crossref_primary_10_3390_jcm12062136
crossref_primary_10_31083_j_rcm2309290
crossref_primary_10_3389_fcvm_2023_1188644
crossref_primary_10_1016_j_shj_2022_100155
crossref_primary_10_3389_fcvm_2023_1154556
crossref_primary_10_1016_j_carrev_2024_05_024
crossref_primary_10_1016_j_jcin_2022_06_001
crossref_primary_10_3390_jcm12010338
crossref_primary_10_2459_JCM_0000000000001324
crossref_primary_10_1016_j_jaccas_2024_102506
crossref_primary_10_1016_j_jacc_2023_02_017
crossref_primary_10_3389_fcvm_2023_1139360
crossref_primary_10_1016_j_cjca_2024_08_268
crossref_primary_10_1002_ccd_30367
crossref_primary_10_1016_j_jcin_2022_07_035
crossref_primary_10_4244_EIJ_D_23_00186
crossref_primary_10_1002_ccd_31171
crossref_primary_10_1093_ehjqcco_qcae100
crossref_primary_10_1161_CIRCINTERVENTIONS_124_014018
crossref_primary_10_1007_s11886_024_02116_4
crossref_primary_10_3390_jcm14061824
crossref_primary_10_4244_EIJ_D_24_00332
crossref_primary_10_3390_jcm13164723
crossref_primary_10_1016_j_ijcard_2023_131572
crossref_primary_10_3389_fcvm_2022_938653
crossref_primary_10_1080_17434440_2024_2401492
crossref_primary_10_1177_26324636241241372
crossref_primary_10_1093_ejcts_ezae021
crossref_primary_10_3389_fcvm_2022_1056496
crossref_primary_10_3390_jcdd9110407
crossref_primary_10_3390_jcm13020373
crossref_primary_10_4244_EIJ_D_22_00958
crossref_primary_10_1016_j_jcin_2023_12_015
crossref_primary_10_1016_j_jcin_2024_08_032
crossref_primary_10_1016_j_ihjcvr_2024_06_002
crossref_primary_10_1016_j_amjcard_2023_01_010
crossref_primary_10_3389_fcvm_2024_1334871
crossref_primary_10_1007_s12265_023_10364_y
crossref_primary_10_3389_fcvm_2022_902564
crossref_primary_10_1016_j_jcin_2022_10_041
crossref_primary_10_1002_ccd_31089
crossref_primary_10_1093_ehjcr_ytae674
crossref_primary_10_1016_j_jaccas_2025_103310
crossref_primary_10_1016_j_jcin_2024_11_008
crossref_primary_10_1136_heartjnl_2024_324802
crossref_primary_10_1002_ccd_31041
crossref_primary_10_1016_j_cjca_2023_09_023
crossref_primary_10_1016_j_amjcard_2023_11_019
crossref_primary_10_3390_jcm12123999
crossref_primary_10_1016_j_carrev_2024_05_004
crossref_primary_10_1161_CIRCINTERVENTIONS_123_013238
crossref_primary_10_1007_s10554_024_03142_7
crossref_primary_10_3390_jcm12237369
crossref_primary_10_1007_s12928_023_00924_z
crossref_primary_10_1016_j_cmpb_2023_107818
crossref_primary_10_1016_j_jcin_2023_04_004
crossref_primary_10_1016_j_jscai_2025_102574
crossref_primary_10_1002_ccd_30828
crossref_primary_10_1016_j_jcin_2023_02_018
crossref_primary_10_3389_fcvm_2024_1362791
crossref_primary_10_4244_EIJ_D_22_00342
crossref_primary_10_1016_j_carrev_2024_04_002
crossref_primary_10_1016_j_jcct_2024_04_014
crossref_primary_10_1016_j_jcin_2024_01_073
crossref_primary_10_1161_CIRCULATIONAHA_124_070502
crossref_primary_10_1016_j_jcin_2022_08_006
crossref_primary_10_1016_j_jcin_2023_05_037
crossref_primary_10_54912_jci_2024_0018
crossref_primary_10_1016_j_repc_2022_10_012
crossref_primary_10_1080_17434440_2023_2184686
crossref_primary_10_1016_j_jcin_2023_01_018
crossref_primary_10_1016_j_jcin_2023_10_033
crossref_primary_10_3390_jcm11226781
crossref_primary_10_1161_CIRCINTERVENTIONS_122_012538
crossref_primary_10_1161_CIRCINTERVENTIONS_122_012657
Cites_doi 10.1002/ccd.27681
10.1016/j.jcin.2019.02.020
10.4244/EIJ-D-20-00067
10.1161/JAHA.120.016446
10.1056/NEJMoa1816885
10.1056/NEJMoa1814052
10.1016/j.jcin.2020.10.031
10.1016/j.jacc.2012.09.001
10.4244/EIJ-D-19-01094
10.1016/j.jacc.2018.01.057
10.1002/ccd.28720
10.1161/CIR.0000000000000923
10.1111/joic.12363
10.1007/s00392-015-0824-5
10.1161/CIRCINTERVENTIONS.120.008972
10.1016/j.jcin.2020.07.006
10.1016/j.jcin.2020.09.022
10.1016/j.jcin.2020.01.202
10.1161/CIRCEP.120.009028
10.1016/j.jcin.2020.02.005
10.1093/eurheartj/ehx489
10.1016/j.jacc.2019.06.012
10.2459/JCM.0000000000000705
10.1016/j.jcin.2019.03.031
10.1016/j.jcin.2019.05.056
10.1016/j.jcin.2018.09.001
10.1016/j.amjcard.2018.07.046
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright_xml – notice: Lippincott Williams & Wilkins
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.1161/CIRCINTERVENTIONS.121.011045
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
EISSN 1941-7632
EndPage e011045
ExternalDocumentID 10.1161/circinterventions.121.011045
35167332
10_1161_CIRCINTERVENTIONS_121_011045
01337495-202202000-00012
Genre Journal Article
GroupedDBID ---
.XZ
.Z2
0R~
18M
53G
5VS
6J9
AAAAV
AAHPQ
AAIQE
AAJCS
AARTV
AASCR
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZZY
ACDDN
ACEWG
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADGGA
ADHPY
AEBDS
AFBFQ
AFDTB
AFEXH
AFNMH
AGINI
AHQNM
AHQVU
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BQLVK
C45
CS3
DIK
DIWNM
E.X
E3Z
EBS
EEVPB
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IN~
JF7
KD2
KQ8
KQB
L-C
O9-
ODMTH
ODZKP
OHYEH
OK1
OPUJH
OVD
OVDNE
OXXIT
P6G
RAH
RLZ
S4S
TEORI
TR2
TSPGW
V2I
W2D
W3M
W8F
WOW
AAYXX
ABZAD
ADKSD
ADNKB
AEETU
AFUWQ
AHRYX
AJNYG
CITATION
DUNZO
EJD
H13
IPNFZ
OUVQU
RIG
ZZMQN
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c4222-1403d78b51474f1b336f2074302c648aa9602ff4f155b56ab0f6c2605babb36e3
IEDL.DBID UNPAY
ISSN 1941-7632
1941-7640
IngestDate Wed Oct 01 16:46:50 EDT 2025
Mon Sep 08 16:12:39 EDT 2025
Wed Feb 19 02:26:28 EST 2025
Wed Oct 01 00:54:37 EDT 2025
Thu Apr 24 22:59:31 EDT 2025
Fri May 16 03:56:59 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords transcatheter aortic valve replacement
aortic valve
heart valve
sinus of Valsalva
coronary angiography
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4222-1403d78b51474f1b336f2074302c648aa9602ff4f155b56ab0f6c2605babb36e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2829-9246
0000-0003-4209-6824
0000-0002-8414-0726
0000-0003-4731-4384
0000-0002-5055-2917
0000-0002-3972-4642
0000-0003-0895-440X
0000-0002-0782-1667
0000-0003-0818-3094
0000-0002-5823-2088
0000-0001-6594-9717
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.ahajournals.org/doi/pdf/10.1161/CIRCINTERVENTIONS.121.011045
PMID 35167332
PQID 2629389029
PQPubID 23479
ParticipantIDs unpaywall_primary_10_1161_circinterventions_121_011045
proquest_miscellaneous_2629389029
pubmed_primary_35167332
crossref_primary_10_1161_CIRCINTERVENTIONS_121_011045
crossref_citationtrail_10_1161_CIRCINTERVENTIONS_121_011045
wolterskluwer_health_01337495-202202000-00012
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-February-01
2022-02-00
20220201
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-February-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation. Cardiovascular interventions
PublicationTitleAlternate Circ Cardiovasc Interv
PublicationYear 2022
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_10_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
References_xml – ident: e_1_3_2_22_2
  doi: 10.1002/ccd.27681
– ident: e_1_3_2_27_2
  doi: 10.1016/j.jcin.2019.02.020
– ident: e_1_3_2_25_2
  doi: 10.4244/EIJ-D-20-00067
– ident: e_1_3_2_26_2
  doi: 10.1161/JAHA.120.016446
– ident: e_1_3_2_3_2
  doi: 10.1056/NEJMoa1816885
– ident: e_1_3_2_2_2
  doi: 10.1056/NEJMoa1814052
– ident: e_1_3_2_17_2
  doi: 10.1016/j.jcin.2020.10.031
– ident: e_1_3_2_11_2
  doi: 10.1016/j.jacc.2012.09.001
– ident: e_1_3_2_24_2
  doi: 10.4244/EIJ-D-19-01094
– ident: e_1_3_2_9_2
  doi: 10.1016/j.jacc.2018.01.057
– ident: e_1_3_2_6_2
  doi: 10.1002/ccd.28720
– ident: e_1_3_2_13_2
  doi: 10.1161/CIR.0000000000000923
– ident: e_1_3_2_7_2
  doi: 10.1111/joic.12363
– ident: e_1_3_2_8_2
  doi: 10.1007/s00392-015-0824-5
– ident: e_1_3_2_15_2
  doi: 10.1161/CIRCINTERVENTIONS.120.008972
– ident: e_1_3_2_5_2
  doi: 10.1016/j.jcin.2020.07.006
– ident: e_1_3_2_19_2
  doi: 10.1016/j.jcin.2020.09.022
– ident: e_1_3_2_18_2
  doi: 10.1016/j.jcin.2020.01.202
– ident: e_1_3_2_21_2
  doi: 10.1161/CIRCEP.120.009028
– ident: e_1_3_2_10_2
  doi: 10.1016/j.jcin.2020.02.005
– ident: e_1_3_2_4_2
  doi: 10.1093/eurheartj/ehx489
– ident: e_1_3_2_14_2
  doi: 10.1016/j.jacc.2019.06.012
– ident: e_1_3_2_12_2
  doi: 10.2459/JCM.0000000000000705
– ident: e_1_3_2_28_2
  doi: 10.1016/j.jcin.2019.03.031
– ident: e_1_3_2_20_2
  doi: 10.1016/j.jcin.2019.05.056
– ident: e_1_3_2_16_2
  doi: 10.1016/j.jcin.2018.09.001
– ident: e_1_3_2_23_2
  doi: 10.1016/j.amjcard.2018.07.046
SSID ssj0063262
Score 2.6024232
Snippet Coronary access (CA) after transcatheter aortic valve replacement (TAVR) with supra-annular transcatheter heart valves (THV) can be challenging. Specific...
SourceID unpaywall
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e011045
SubjectTerms Aortic Valve - diagnostic imaging
Aortic Valve - surgery
Aortic Valve Stenosis - diagnostic imaging
Aortic Valve Stenosis - surgery
Heart Valve Prosthesis
Humans
Prosthesis Design
Retrospective Studies
Transcatheter Aortic Valve Replacement - adverse effects
Treatment Outcome
Title Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01337495-202202000-00012
https://www.ncbi.nlm.nih.gov/pubmed/35167332
https://www.proquest.com/docview/2629389029
https://www.ahajournals.org/doi/pdf/10.1161/CIRCINTERVENTIONS.121.011045
UnpaywallVersion publishedVersion
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1941-7632
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0063262
  issn: 1941-7632
  databaseCode: KQ8
  dateStart: 20080801
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1941-7632
  dateEnd: 20241101
  omitProxy: true
  ssIdentifier: ssj0063262
  issn: 1941-7632
  databaseCode: DIK
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED9tnQSaEB-CQRFMRtprSmI7TgpPUbTR8VEBomM8RXYSs2hRUvWDqfz1-JyktPQFIaQ8JLJsK-effXe-888AJ9KscMNcYILDUDqcM9cJZUadVFGeaZ2bQceI7oexGE3420v_cg9G3VkYTKuUV7IV5NzG8nFyTzPdTHDhvYzPP8eWMPbidGzP2iJFwgAVGff34UD4xirvwcFk_DH6ZoPK3HPMNKK_37l7C0665tJilhYbCYbzjea2tdWOCXoIt5fVVK5uZFkewp2bGiPc82ub4L6hps7uQdH9YJOdcj1YLtQg_fkH9-P_kMB9uNvasiRqwPcA9vLqIdQxciLI2YpE9i5GEuEt5MTqRMsRi19RjXXIhSx_5MT4ALiXj9uU5GuxuCJ4aAXxMMPGy-K7TVh4RQyiSfT-_M3YieLY4IZgDuTqEUzOTr_EI6e91cFJcbvJQYLALAiVsdQCrj3FmNAUDRmXpoKHUprRo1qbIt9XvpDK1SJFr0tJpZjI2RH0qrrKnwChOtA8TZHFUHMp8zBzjcqnggVS0FAHfXjdjV6StpTnePNGmVjXR3jJjiATI8ikEWQf_HXtaUP98Zf1XnRASYy0MAAjq7xezhMqjHGFgd1hHx43CFq3zHxPBIzRPog1pHa63YHqVrfOFv6S5iCtKWUsMG6wWQ-peVomAY8-_deOnkFvMVvmz40xtlDHsP_uU3jczrZf72MvRA
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_OPVAO8QM9XVGJcK9dt0madvWplDv3RBcR9zyfSpI2XrnSLvvhsf71ZtJ23XVfRIQ-tIQkdPJLZiYz-QXgRNoVbpQLTHAYSY9zNvQimVFPK8ozY3I76BjR_TgR4yl_fxlcHsC4OwuDaZXySraCXLhYPk7uWWaaCS7818n558QRxl6cTtxZW6RIGKAi48EtOBSBtcp7cDidfIq_uaAy9z07jejvdz68DSddc7qY62IrwXCx1dyuttozQY_gzqqayfWNLMsjuHtTY4R7ce0S3LfU1Nl9KLofbLJTrgerpRron39wP_4PCTyAe60tS-IGfA_hIK8eQZ0gJ4Kcr0ns7mIkMd5CTpxOdByx-BXXWIdcyPJHTqwPgHv5uE1JvhbLK4KHVhAPc2y8LL67hIU3xCKaxB_O3028OEksbgjmQK4fw_Ts9Esy9tpbHTyN200eEgRmYaSspRZy4yvGhKFoyAypFjyS0o4eNcYWBYEKhFRDIzR6XUoqxUTOjqFX1VX-FAg1oeFaI4uh4VLmUTa0Kp8KFkpBIxP24W03eqluKc_x5o0yda6P8NM9QaZWkGkjyD4Em9qzhvrjL-u96oCSWmlhAEZWeb1apFRY4woDu6M-PGkQtGmZBb4IGaN9EBtI7XW7B9Wdbr0d_KXNQVpbylho3WC7HlL7tEwCPn32rx09h95yvspfWGNsqV628-wX2XcuTw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronary+Access+After+Transcatheter+Aortic+Valve+Replacement+With+Commissural+Alignment%3A+The+ALIGN-ACCESS+Study&rft.jtitle=Circulation.+Cardiovascular+interventions&rft.au=Tarantini%2C+Giuseppe&rft.au=Nai+Fovino%2C+Luca&rft.au=Scotti%2C+Andrea&rft.au=Massussi%2C+Mauro&rft.date=2022-02-01&rft.eissn=1941-7632&rft.volume=15&rft.issue=2&rft.spage=e011045&rft_id=info:doi/10.1161%2FCIRCINTERVENTIONS.121.011045&rft_id=info%3Apmid%2F35167332&rft.externalDocID=35167332
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-7632&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-7632&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-7632&client=summon